Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Kang WY"" wg kryterium: Autor

  Lista filtrów
Wyrównaj
Wyświetlanie 1-20 z 47
Tytuł:
Pharmacokinetics and Pharmacodynamics of YYD601, a Dual Delayed-Release Formulation of Esomeprazole, Following Single and Multiple Doses in Healthy Adult Volunteers Under Fasting and Fed Conditions
Autorzy:
Lee HW
Kang WY
Jung W
Gwon MR
Cho K
Yoon YR
Seong SJ
Pokaż więcej
Temat:
esomeprazole
dual delayed release
pharmacokinetics
pharmacodynamics
Therapeutics. Pharmacology
RM1-950
Źródło:
Drug Design, Development and Therapy, Vol Volume 16, Pp 619-634 (2022)
Opis pliku:
electronic resource
Relacje:
https://www.dovepress.com/pharmacokinetics-and-pharmacodynamics-of-yyd601-a-dual-delayed-release-peer-reviewed-fulltext-article-DDDT; https://doaj.org/toc/1177-8881
Dostęp URL:
https://doaj.org/article/51981fc0ea6d4986aaa6432a1a9306b1  Link otwiera się w nowym oknie
Czasopismo naukowe
Szczegóły
Tytuł:
A Pharmacokinetic Drug Interaction Between Fimasartan and Linagliptin in Healthy Volunteers
Autorzy:
Kang WY
Lee HW
Gwon MR
Cho S
Shim WS
Lee KT
Yang DH
Seong SJ
Yoon YR
Pokaż więcej
Temat:
fimasartan
pharmacokinetics
drug-drug interaction
linagliptin
safety
Therapeutics. Pharmacology
RM1-950
Źródło:
Drug Design, Development and Therapy, Vol Volume 14, Pp 2101-2111 (2020)
Opis pliku:
electronic resource
Relacje:
https://www.dovepress.com/a-pharmacokinetic-drug-interaction-between-fimasartan-and-linagliptin--peer-reviewed-article-DDDT; https://doaj.org/toc/1177-8881
Dostęp URL:
https://doaj.org/article/f6b6f8eef6f94c998c98346d00541ddf  Link otwiera się w nowym oknie
Czasopismo naukowe
Szczegóły
Tytuł:
Pharmacokinetic and bioequivalence study between two formulations of S-1 in Korean gastric cancer patients
Autorzy:
Lee HW
Seong SJ
Kang WY
Ohk B
Gwon MR
Kim BK
Cho S
Cho K
Sung YK
Yoon YR
Kim JG
Pokaż więcej
Temat:
S-1
pharmacokinetics
bioequivalence
tegafur
gimeracil
oteracil
Therapeutics. Pharmacology
RM1-950
Źródło:
Drug Design, Development and Therapy, Vol Volume 13, Pp 3127-3136 (2019)
Opis pliku:
electronic resource
Relacje:
https://www.dovepress.com/pharmacokinetic-and-bioequivalence-study-between-two-formulations-of-s-peer-reviewed-article-DDDT; https://doaj.org/toc/1177-8881
Dostęp URL:
https://doaj.org/article/22786a18286e4f7bb8a06b67e8ffd8fa  Link otwiera się w nowym oknie
Czasopismo naukowe
Szczegóły
Tytuł:
Pharmacokinetic and bioequivalence study comparing a fimasartan/rosuvastatin fixed-dose combination with the concomitant administration of fimasartan and rosuvastatin in healthy subjects
Autorzy:
Kang WY
Seong SJ
Ohk B
Gwon MR
Kim BK
Cho S
Shim WS
Lee KT
Kim EH
Yang DH
Lee HW
Yoon YR
Pokaż więcej
Temat:
fixed-dose combination
pharmacokinetics
bioequivalence
fimasartan
rosuvastatin
Therapeutics. Pharmacology
RM1-950
Źródło:
Drug Design, Development and Therapy, Vol Volume 12, Pp 3607-3615 (2018)
Opis pliku:
electronic resource
Relacje:
https://www.dovepress.com/pharmacokinetic-and-bioequivalence-study-comparing-a-fimasartanrosuvas-peer-reviewed-article-DDDT; https://doaj.org/toc/1177-8881
Dostęp URL:
https://doaj.org/article/53d18f5ce71e4000a15d9c7ad1b9f6e7  Link otwiera się w nowym oknie
Czasopismo naukowe
Szczegóły
Tytuł:
Pharmacokinetic and bioequivalence study of a telmisartan/S-amlodipine fixed-dose combination (CKD-828) formulation and coadministered telmisartan and S-amlodipine in healthy subjects
Autorzy:
Kang WY
Seong SJ
Ohk B
Gwon M
Kim BK
La S
Kim HJ
Cho S
Yoon Y
Yang DH
Lee HW
Pokaż więcej
Temat:
fixed-dose combination
pharmacokinetics
S-amlodipine
telmisartan
safety
Therapeutics. Pharmacology
RM1-950
Źródło:
Drug Design, Development and Therapy, Vol Volume 12, Pp 545-553 (2018)
Opis pliku:
electronic resource
Relacje:
https://www.dovepress.com/pharmacokinetic-and-bioequivalence-study-of-a-telmisartans-amlodipine--peer-reviewed-article-DDDT; https://doaj.org/toc/1177-8881
Dostęp URL:
https://doaj.org/article/286070fe76d54f01ba4b59d1d964040b  Link otwiera się w nowym oknie
Czasopismo naukowe
Szczegóły
Tytuł:
Fed and fasted bioequivalence assessment of two formulations of extended-release fixed-dose combination dapagliflozin/metformin (10/1,000 mg) tablets in healthy subjects.
Autorzy:
Lee HW; School of Medicine, Kyungpook National University and Department of Clinical Pharmacology, Kyungpook National University Hospital, Daegu 41944, Korea.
Kang WY; Clinical Trial Dossier Evaluation Team, Department of Innovative Products Support, National Institute of Food and Drug Safety Evaluation, Cheongju 28159, Korea.
Park JS; School of Medicine, Kyungpook National University and Department of Clinical Pharmacology, Kyungpook National University Hospital, Daegu 41944, Korea.
Lee JH; School of Medicine, Kyungpook National University and Department of Clinical Pharmacology, Kyungpook National University Hospital, Daegu 41944, Korea.
Gwon MR; School of Medicine, Kyungpook National University and Department of Clinical Pharmacology, Kyungpook National University Hospital, Daegu 41944, Korea.
Yang DH; Division of Cardiology, Department of Internal Medicine, Kyungpook National University Hospital, Daegu 41944, Korea.
Kim EH; College of Nursing, Catholic University of Daegu, Gyeongsan 38430, Korea.
Park SJ; College of Korean Medicine, Daegu Haany University, Daegu 38610, Korea.
Yoon YR; School of Medicine, Kyungpook National University and Department of Clinical Pharmacology, Kyungpook National University Hospital, Daegu 41944, Korea.
Seong SJ; School of Medicine, Kyungpook National University and Department of Clinical Pharmacology, Kyungpook National University Hospital, Daegu 41944, Korea.
Pokaż więcej
Źródło:
Translational and clinical pharmacology [Transl Clin Pharmacol] 2023 Jun; Vol. 31 (2), pp. 105-113. Date of Electronic Publication: 2023 Jun 26.
Typ publikacji:
Journal Article
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
A randomized, open-label, single-dose, two-way crossover study to assess the pharmacokinetics between two tablets of fixed-dose combination formulation with raloxifene and cholecalciferol and concomitant administration of each agents in healthy male volunteers.
Autorzy:
Lee HW; Department of Clinical Pharmacology, Kyungpook National University Hospital, Daegu 41944, Korea.
Kang WY; Department of Clinical Pharmacology, Kyungpook National University Hospital, Daegu 41944, Korea.
Gwon MR; Department of Clinical Pharmacology, Kyungpook National University Hospital, Daegu 41944, Korea.; Department of Molecular Medicine, School of Medicine, Kyungpook National University, Daegu 41944, Korea.
Choi EJ; Department of Clinical Pharmacology, Kyungpook National University Hospital, Daegu 41944, Korea.; Clinical Omics Institute, School of Medicine, Kyungpook National University, Daegu 41944, Korea.
Kim EH; College of Nursing, Daegu Catholic University, Gyeongsan 38430, Korea.
Cho K; Analytical Research Division, Biocore Co. Ltd., Seoul 08511, Korea.
Lee B; Department of Clinical Development, Alvogen Korea Co. Ltd., Seoul 07326, Korea.
Seong SJ; Department of Clinical Pharmacology, Kyungpook National University Hospital, Daegu 41944, Korea.; Department of Molecular Medicine, School of Medicine, Kyungpook National University, Daegu 41944, Korea.
Yoon YR; Department of Clinical Pharmacology, Kyungpook National University Hospital, Daegu 41944, Korea.; Department of Molecular Medicine, School of Medicine, Kyungpook National University, Daegu 41944, Korea.
Pokaż więcej
Źródło:
Translational and clinical pharmacology [Transl Clin Pharmacol] 2022 Sep; Vol. 30 (3), pp. 136-144. Date of Electronic Publication: 2022 Sep 15.
Typ publikacji:
Journal Article
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Pharmacokinetic Drug Interaction Between Raloxifene and Cholecalciferol in Healthy Volunteers.
Autorzy:
Lee HW; Department of Molecular Medicine, School of Medicine, Kyungpook National University, Daegu, Republic of Korea.; Department of Clinical Pharmacology, Kyungpook National University Hospital, Daegu, Republic of Korea.
Kang WY; Department of Molecular Medicine, School of Medicine, Kyungpook National University, Daegu, Republic of Korea.; Department of Clinical Pharmacology, Kyungpook National University Hospital, Daegu, Republic of Korea.
Jung W; Department of Molecular Medicine, School of Medicine, Kyungpook National University, Daegu, Republic of Korea.; Department of Clinical Pharmacology, Kyungpook National University Hospital, Daegu, Republic of Korea.
Gwon MR; Department of Molecular Medicine, School of Medicine, Kyungpook National University, Daegu, Republic of Korea.; Department of Clinical Pharmacology, Kyungpook National University Hospital, Daegu, Republic of Korea.
Cho K; Analytical Research Division, Biocore Co. Ltd., Seoul, Republic of Korea.
Lee B; Department of Clinical Development, Alvogen Korea Co. Ltd., Seoul, Republic of Korea.
Seong SJ; Department of Molecular Medicine, School of Medicine, Kyungpook National University, Daegu, Republic of Korea.; Department of Clinical Pharmacology, Kyungpook National University Hospital, Daegu, Republic of Korea.
Yoon YR; Department of Molecular Medicine, School of Medicine, Kyungpook National University, Daegu, Republic of Korea.; Department of Clinical Pharmacology, Kyungpook National University Hospital, Daegu, Republic of Korea.
Pokaż więcej
Źródło:
Clinical pharmacology in drug development [Clin Pharmacol Drug Dev] 2022 May; Vol. 11 (5), pp. 623-631. Date of Electronic Publication: 2022 Jan 04.
Typ publikacji:
Clinical Trial, Phase I; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms:
Cholecalciferol*/adverse effects
Raloxifene Hydrochloride*/adverse effects
Adult ; Cross-Over Studies ; Drug Interactions ; Healthy Volunteers ; Humans ; Male
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
External validation of deep learning-based bone-age software: a preliminary study with real world data.
Autorzy:
Lea WW; Department of Radiology, Guro Hospital, Korea University College of Medicine, Seoul, Republic of Korea.
Hong SJ; Department of Radiology, Guro Hospital, Korea University College of Medicine, Seoul, Republic of Korea. .
Nam HK; Department of Pediatrics Endocrinology, Guro Hospital, Korea University College of Medicine, Seoul, Republic of Korea.
Kang WY; Department of Radiology, Guro Hospital, Korea University College of Medicine, Seoul, Republic of Korea.
Yang ZP; Smart Health-Care Center, Guro Hospital, Korea University College of Medicine, Seoul, Republic of Korea.
Noh EJ; Smart Health-Care Center, Guro Hospital, Korea University College of Medicine, Seoul, Republic of Korea.
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2022 Jan 24; Vol. 12 (1), pp. 1232. Date of Electronic Publication: 2022 Jan 24.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't; Validation Study
MeSH Terms:
Age Determination by Skeleton*
Deep Learning*
Adolescent ; Child ; Child, Preschool ; Feasibility Studies ; Female ; Hand Bones/diagnostic imaging ; Humans ; Male ; Radiography
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Evaluation of the Pharmacokinetic Drug-Drug Interaction between Micronized Fenofibrate and Pitavastatin in Healthy Volunteers.
Autorzy:
Lee HW; Department of Molecular Medicine, School of Medicine, Kyungpook National University and Department of Clinical Pharmacology, Kyungpook National University Hospital, Daegu 41566, Korea.
Kang WY; Department of Molecular Medicine, School of Medicine, Kyungpook National University and Department of Clinical Pharmacology, Kyungpook National University Hospital, Daegu 41566, Korea.
Jung W; Department of Molecular Medicine, School of Medicine, Kyungpook National University and Department of Clinical Pharmacology, Kyungpook National University Hospital, Daegu 41566, Korea.
Gwon MR; Department of Molecular Medicine, School of Medicine, Kyungpook National University and Department of Clinical Pharmacology, Kyungpook National University Hospital, Daegu 41566, Korea.
Cho K; Analytical Research Division, Biocore Co. Ltd., Seoul 08511, Korea.
Yang DH; Division of Cardiology, Department of Internal Medicine, School of Medicine, Kyungpook National University, Daegu 41944, Korea.
Yoon YR; Department of Molecular Medicine, School of Medicine, Kyungpook National University and Department of Clinical Pharmacology, Kyungpook National University Hospital, Daegu 41566, Korea.
Seong SJ; Department of Molecular Medicine, School of Medicine, Kyungpook National University and Department of Clinical Pharmacology, Kyungpook National University Hospital, Daegu 41566, Korea.
Pokaż więcej
Źródło:
Pharmaceutics [Pharmaceutics] 2020 Sep 12; Vol. 12 (9). Date of Electronic Publication: 2020 Sep 12.
Typ publikacji:
Journal Article
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Wyświetlanie 1-20 z 47

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies